Latest Breaking News On - Neuroendocrine tumours - Page 2 : comparemela.com

Novartis Pharma AG: Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced gastroenteropancreatic neuroendocrine tumors

Novartis Pharma AG: Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced gastroenteropancreatic neuroendocrine tumors
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Switzerland
China
Toronto
Ontario
Canada
Sunnybrook
Alberta
Ivrea
Piemonte
Italy
United-states
Haiyan

Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced gastroenteropancreatic neuroendocrine tumors

In the Phase III NETTER-2 trial, Lutathera plus octreotide LAR significantly extended median PFS to 22.8 months vs. 8.5 months with high-dose octreotide LAR in patients with newly diagnosed grade 2.

United-states
Haiyan
Yunnan
China
Italy
Sasayama
Hyogo
Japan
Canada
Spain
Zhejiang
Zaragoza

Parkinson's Disease Pipeline, Clinical Trials Stage Products,

Parkinson's Disease Pipeline, Clinical Trials Stage Products,
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Germany
Italy
United-kingdom
Japan
France
United-states
Spain
Tumours-market-insights
Neuroendocrine-tumours
Download-sample-report
Neuroendocrine-tumour-overview

25,550+ Australians and counting: The growing need for neuroendocrine cancer care

25,550+ Australians and counting: The growing need for neuroendocrine cancer care
manningrivertimes.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from manningrivertimes.com.au Daily Mail and Mail on Sunday newspapers.

Australia
Australians
Australian
Aretha-franklin
Steve-jobs
Meredith-cummins
Irritable-bowel-syndrome
Neuroendocrine-cancer-australia
Neuroendocrine-tumours
Neuroendocrine-cancer
Endocrine-cancer-australia

Motor Neuron Disease Market to Expand at a Significant Growth

Motor Neuron Disease Market to Expand at a Significant Growth
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
United-states
Germany
France
Japan
Italy
Spain
Tumours-market-insights
Neuroendocrine-tumours
Download-sample-report
Neuroendocrine-tumour-overview